The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
Also known as: Iron and TIBC, Iron and Total Iron Binding Capacity TIBC, TIBC
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
Also known as: Reverse T3, Reverse Triiodothyronine, RT3, T3 Reverse RT3 LCMSMS, Triiodothyronine Reverse
Also known as: Triiodothyronine
Also known as: Free T3, FT3, T3 Free
Also known as: T4 Thyroxine Total
Also known as: Free T4, FT4, T4 Free
Also known as: Thyroid Stimulating Hormone, Thyroid Stimulating Hormone (TSH), Thyrotropin
Also known as: B12, B12 Vitamin, Cobalamin, Cyanocobalamin, Vitamin B12 Cobalamin
The TH-2. Hashimoto's Disease panel contains 13 tests with 78 biomarkers.
Brief Description: The TH-2 Hashimoto's Disease panel is a comprehensive set of tests designed for the in-depth evaluation of Hashimoto's thyroiditis, an autoimmune disorder that is the most common cause of hypothyroidism. This panel extends beyond basic thyroid function tests to include assessments that evaluate the overall health impact of the disease, offering a holistic view of the patient's condition.
Collection Method: Blood Draw
Specimen Type: Whole Blood and Serum
Test Preparation: Patient should be fasting 9-12 hours prior to collection.
Collection should be done in the morning.
Specifc to TSH: Specimen collection after fluorescein dye angiography should be delayed for at least 3 days. For patients on hemodialysis, specimen collection should be delayed for 2 weeks.
According to the assay manufacturer Siemens: "Samples containing fluorescein can produce falsely depressed values when tested with the Advia Centaur TSH3 Ultra assay."
Healthcare providers may order the TH-2 Hashimoto's Disease panel for patients presenting symptoms indicative of hypothyroidism, such as fatigue, weight gain, cold intolerance, and dry skin, which could suggest Hashimoto's thyroiditis. It's also valuable for monitoring the disease's progression and the effectiveness of thyroid hormone replacement therapy, as well as identifying potential complications associated with the condition.
While the TH-2 Hashimoto's Disease panel offers a thorough assessment of thyroid function and its broader health implications, the TH-3 and TH-4 panels provide an even more in-depth evaluation, especially focusing on the autoimmune characteristics of the disease.
TH-3 Hashimoto's Disease Panel: Enhances the TH-2 panel by including thyroid antibody tests (Thyroid Peroxidase Antibodies and Thyroglobulin Antibodies), which are critical for confirming the autoimmune nature of Hashimoto's thyroiditis. The addition of Vitamin B6 further aids in assessing neurological health and metabolic function.
TH-4 Hashimoto's Disease Panel: The most comprehensive panel, TH-4, includes all the tests in TH-3 and adds TSH Receptor Binding Antibody and Thyroid Stimulating Immunoglobulin tests, offering insights into more complex and less common aspects of thyroid autoimmunity, providing a complete picture of the disease's impact.
The TH-2 Hashimoto's Disease panel is primarily used to diagnose and manage Hashimoto's thyroiditis. It helps in detecting hypothyroidism through elevated TSH and potentially low T4 levels. The panel also aids in identifying common complications or coexisting conditions, such as anemia, dyslipidemia, vitamin deficiencies, and metabolic syndrome.
Healthcare professionals utilize the results of the TH-2 Hashimoto's Disease panel to diagnose Hashimoto's thyroiditis, evaluate the extent of thyroid dysfunction, and monitor the effectiveness of treatment. The comprehensive nature of the panel also allows for the management of associated conditions, ensuring a holistic approach to patient care.
The TH-2 Hashimoto's Disease panel plays a crucial role in the comprehensive assessment and management of Hashimoto's thyroiditis, providing valuable insights into both thyroid function and the broader health impacts of the disease. By offering a wide range of metabolic, nutritional, and hormonal assessments, this panel enables healthcare providers to develop a nuanced understanding of the patient's condition, facilitating tailored treatment strategies. For those requiring further investigation into the autoimmune aspects of the disease, the TH-3 and TH-4 panels offer additional diagnostic capabilities, enhancing the ability to address the complexities of Hashimoto's thyroiditis.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.